BioDelivery Sciences International Calls Meeting With FDA Positive; BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug

Triangle Business Journal -- Biodelivery Sciences International’s stock closed up more than 5 percent on Thursday after the company announced it had a positive meeting with the U.S. Food and Drug Administration regarding its drug Onsolis.